IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v16y2019i18p3428-d267552.html
   My bibliography  Save this article

Effect of Specific Retinoic Acid Receptor Agonists on Noise-Induced Hearing Loss

Author

Listed:
  • Sang Hyun Kwak

    (Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul 03722, Korea)

  • Gi-Sung Nam

    (Department of Otorhinolaryngology, Chonbuk National University College of Medicine, Jeonju 54907, Korea)

  • Seong Hoon Bae

    (Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul 03722, Korea)

  • Jinsei Jung

    (Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul 03722, Korea)

Abstract

Noise is one of the most common causes of hearing loss in industrial countries. There are many studies about chemical agents to prevent noise-induced hearing loss (NIHL). However, there is no commercially available drug yet. Retinoic acid is an active metabolite of Vitamin A; it has an anti-apoptic role in NIHL. This study aims to verify the differences among selective agonists of retinoic acid receptors (RARs) in NIHL. All-trans retinoic acid (ATRA), AM80 (selective retinoic acid receptor α agonist), AC261066 (Selective retinoic acid receptor β1 agonist), and CD1530 (Selective retinoic acid λ agonist) were injected to 6–7 weeks old CJ5BL/6 mice before noise (110 dB for 3 h) exposure. In the auditory brainstem response test pre-, post 1, 3, and 7 days after noise exposure, not only ATRA but all kinds of selective RAR agonists showed protective effects in hearing threshold and wave I amplitude. Though there was no significant difference in the level of protective effects between agonists, α agonist showed the most prominent effect in preserving hearing function as well as outer hair cells after noise exposure. In conclusion, selective agonists of RAR demonstrate comparable protective effects against NIHL to retinoic acid. Given that these selective RAR agonists have less side effects than retinoic acid, they may be promising potential drugs against NIHL.

Suggested Citation

  • Sang Hyun Kwak & Gi-Sung Nam & Seong Hoon Bae & Jinsei Jung, 2019. "Effect of Specific Retinoic Acid Receptor Agonists on Noise-Induced Hearing Loss," IJERPH, MDPI, vol. 16(18), pages 1-8, September.
    • Handle: RePEc:gam:jijerp:v:16:y:2019:i:18:p:3428-:d:267552
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/16/18/3428/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/16/18/3428/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:16:y:2019:i:18:p:3428-:d:267552. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.